New Insights into the Effects of SARS-CoV-2 on Metabolic Organs: A Narrative Review of COVID-19 Induced Diabetes release_4qyr6luv7rgalibmnkq2r5ifii

by Lu Li, Lin Li, Xianhui Cai, Zongfu Pan

Published in Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy by Informa UK Limited.

2024   Volume Volume 17, p1383-1389

Abstract

Coronavirus disease 2019 (COVID-19)-induced new-onset diabetes has raised widespread concerns. Increased glucose concentration and insulin resistance levels were observed in the COVID-19 patients. COVID-19 patients with newly diagnosed diabetes may have worse clinical outcomes and can have serious consequences. The types and exact mechanisms of COVID-19-caused diabetes are not well understood. Understanding the direct effects of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on pancreatic beta cells and insulin target metabolism organs, such as the liver, muscle, and adipose tissues, will provide new ideas for preventing and treating the new-onset diabetes induced by COVID-19.
In text/plain format

Archived Files and Locations

application/pdf   688.3 kB
file_zw2srckmpfhnhiwgztfqjeap5i
www.dovepress.com (publisher)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2024-03-21
Language   en ?
Container Metadata
Open Access Publication
In DOAJ
In Keepers Registry
ISSN-L:  1178-7007
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: dfa53ec2-e7bd-4915-823c-9248098e0e67
API URL: JSON